146 results on '"Rosina, Silvia"'
Search Results
2. Skin manifestations help identifying different phenotypes of paediatric SAPHO syndrome
3. Defining Criteria for Disease Activity States in Systemic Juvenile Idiopathic Arthritis Based on the Systemic Juvenile Arthritis Disease Activity Score.
4. Therapeutic Role of HPV Vaccination on Benign HPV-induced Epithelial Proliferations in Immunocompetent and Immunocompromised Patients: Case Study and Review of the Literature.
5. Defining criteria for disease activity states in juvenile dermatomyositis based on the Juvenile Dermatomyositis Activity Index
6. Determinants of Discordance Between Criteria for Inactive Disease and Low Disease Activity in Juvenile Idiopathic Arthritis
7. Outcome Scores in Pediatric Rheumatology
8. Pediatric Antiphospholipid Syndrome: from Pathogenesis to Clinical Management
9. Clinical features, treatment and outcomes of Italian children with enthesitis-related arthritis and juvenile psoriatic arthritis: a cross-sectional cohort study
10. A prediction rule for lack of achievement of inactive disease with methotrexate as the sole disease-modifying antirheumatic therapy in juvenile idiopathic arthritis
11. Juvenile Psoriatic Arthritis: Myth or Reality? An Unending Debate
12. Standardized nailfold capillaroscopy in children with rheumatic diseases : a worldwide study
13. Emerging therapies for juvenile arthritis: agents in early clinical trials
14. Innovative Research Design to Meet the Challenges of Clinical Trials for Juvenile Dermatomyositis
15. Drivers of non-zero physician global scores during periods of inactive disease in juvenile idiopathic arthritis
16. Tapering Canakinumab Monotherapy in Patients with Systemic Juvenile Idiopathic Arthritis in Clinical Remission: Results from an Open‐label, Randomized Phase IIIb/IV Study
17. Is Anti-NXP2 Autoantibody a Risk Factor for Calcinosis and Poor Outcome in Juvenile Dermatomyositis Patients? Case Series
18. Disparities in the prevalence of clinical features between systemic juvenile idiopathic arthritis and adult-onset Still’s disease
19. Novel biomarkers for prediction of outcome and therapeutic response in juvenile idiopathic arthritis
20. A prediction rule for polyarticular extension in oligoarticular-onset juvenile idiopathic arthritis
21. Multisystem Inflammatory Syndrome in Children: Unique Disease or Part of the Kawasaki Disease Spectrum?
22. Development and testing of reduced versions of the MMT-8 in juvenile dermatomyositis
23. Performance of Current Guidelines for Diagnosis of Macrophage Activation Syndrome Complicating Systemic Juvenile Idiopathic Arthritis
24. Analysis of arthritis flares after achievement of inactive disease with methotrexate monotherapy in juvenile idiopathic arthritis
25. Giant Urticaria and Acral Peeling in a Child with Coronavirus Disease 2019
26. Giant Urticaria and Acral Peeling in a Child with COVID-19
27. Vascular malformations
28. Sensitivity and specificity of current diagnostic guidelines in children with macrophage activation syndrome complicating systemic juvenile idiopathic arthritis
29. Development and Testing of Reduced Versions of the Manual Muscle Test-8 in Juvenile Dermatomyositis
30. Update on Outcome Measures for Pediatric Systemic Lupus Erythematosus
31. Is Macrophage Activation Syndrome in Kawasaki Disease Underrecognized?
32. MEASUREMENT PERFORMANCE OF REDUCED VERSIONS OF MUSCLE STRENGTH TOOLS IN JUVENILE DERMATOMYOSITIS
33. Development and validation of a composite disease activity score for juvenile dermatomyositis
34. Development and validation of a composite disease activity score for measurement of muscle and skin involvement in juvenile dermatomyositis
35. Development and validation of a composite disease activity score for measurement of muscle and skin involvement in juvenile dermatomyositis
36. Development and Testing of Reduced Versions of the Manual Muscle Test-8 in Juvenile Dermatomyositis.
37. SAT0501 THE IMPACT OF MORNING STIFFNESS ON THE DEFINITION OF INACTIVE DISEASE IN JUVENILE IDIOPATHIC ARTHRITIS
38. THU0507 TYPE I INTERFERON SCORE AND INTERFERON INDUCED MEDIATORS CXCL10 AND NEOPTERIN ARE CORRELATED WITH DISEASE ACTIVITY IN JUVENILE DERMATOMYOSITIS
39. FRI0571 MEASUREMENT PERFORMANCE OF REDUCED VERSIONS OF MUSCLE STRENGTH TOOLS IN JUVENILE DERMATOMYOSITIS
40. Muscle Expression of Type I and Type II Interferons Is Increased in Juvenile Dermatomyositis and Related to Clinical and Histologic Features
41. Development and validation of a composite disease activity score for measurement of muscle and skin involvement in juvenile dermatomyositis
42. Development and Testing of a Hybrid Measure of Muscle Strength in Juvenile Dermatomyositis for Use in Routine Care
43. Recent therapeutic advances in juvenile idiopathic arthritis
44. Is Macrophage Activation Syndrome in Kawasaki Disease Underrecognized?
45. Performance of Current Guidelines for Diagnosis of Macrophage Activation Syndrome Complicating Systemic Juvenile Idiopathic Arthritis
46. Morte e diritto. Riflessioni sulla fine della vita dell'uomo postmoderno
47. Interstitial de novo 18q22.3q23 deletion: clinical, neuroradiological and molecular characterization of a new case and review of the literature
48. Società di gestione dei servizi pubblici locali. La nuova governance tra spending review, quote rosa ed anticorruzione
49. L'ultima Soglia. Sull'evoluzione del concetto di morte nell'ordinamento italiano
50. Glucocorticoids in Juvenile Idiopathic Arthritis
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.